Ausgabe 1/2019
Inhalt (32 Artikel)
Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
Peter D. Burbelo, Sarah Browne, Steve M. Holland, Michael J. Iadarola, Ilias Alevizos
Pancreatic cancer microenvironment: a current dilemma
Burak Uzunparmak, Ibrahim Halil Sahin
The effect of omega-3 fatty acids on clinical and paraclinical features of intractable epileptic patients: a triple blind randomized clinical trial
Shaghayegh Omrani, Mohammad Taheri, Mir Davood Omrani, Shahram Arsang-Jang, Soudeh Ghafouri-Fard
EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
Thang Thanh Phan, Bich-Thu Tran, Son Truong Nguyen, Toan Trong Ho, Hang Thuy Nguyen, Vu Thuong Le, Anh Tuan Le
Expression of Concern to: Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases
Hanan Polansky, Edan Itzkovitz, Adrian Javaherian
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Mojtaba Khazaei, Fateme Ghasemian, Mehrdokht Mazdeh, Mohammad Taheri, Soudeh Ghafouri-Fard
Impact of fatty acid binding protein 5-deficiency on COPD exacerbations and cigarette smoke-induced inflammatory response to bacterial infection
Deviyani M. Rao, Della T. Phan, Michelle J. Choo, Michael R. Weaver, Rebecca E. Oberley-Deegan, Russell P. Bowler, Fabienne Gally
Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy
Anna Pasto, Federica Giordano, Michael Evangelopoulos, Alberto Amadori, Ennio Tasciotti
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
Jun Gong, Alexander Chehrazi-Raffle, Veronica Placencio-Hickok, Michelle Guan, Andrew Hendifar, Ravi Salgia
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
S. K. Daniel, K. M. Sullivan, K. P. Labadie, V. G. Pillarisetty
A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
Mehrdokht Mazdeh, Shahriar Kargar Monhaser, Mohammad Taheri, Soudeh Ghafouri-Fard
Role of medical and molecular imaging in COPD
Lukasz A. Myc, Yun M. Shim, Victor E. Laubach, Julien Dimastromatteo
Epigenetics of hepatocellular carcinoma
Tan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow
Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer
Hanifeh Mirtavoos-Mahyari, Soudeh Ghafouri-Fard, Adnan Khosravi, Elahe Motevaseli, Zahra Esfahani-Monfared, Sharareh Seifi, Babak Salimi, Vahid Kholghi Oskooei, Mohsen Ghadami, Mohammad Hossein Modarressi
Clinical applications of fucoidan in translational medicine for adjuvant cancer therapy
Hsien-Yeh Hsu, Pai-An Hwang
The significance of microbiome in personalized medicine
Ava Behrouzi, Amir Hossein Nafari, Seyed Davar Siadat
Genetics in primary care: validating a tool to pre-symptomatically assess common disease risk using an Australian questionnaire on family history
Elisa J. F. Houwink, Olga R. Hortensius, Kees van Boven, Annet Sollie, Mattijs E. Numans
Circulating monocytes and tumor-associated macrophages express recombined immunoglobulins in glioblastoma patients
Svenja Busch, Marina Talamini, Steffen Brenner, Amr Abdulazim, Daniel Hänggi, Michael Neumaier, Marcel Seiz-Rosenhagen, Tina Fuchs
The use of leukocytes’ secretome to individually target biological therapy in autoimmune arthritis: a case report
Patrice E. Poubelle, Nathalie Pagé, Marie-Pier Longchamps, Natalia Sampaio Moura, David B. Beck, Ivona Aksentijevich, Philippe A. Tessier, Martin Pelletier
Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis
Mojtaba Khazaei, Ashkan Karevan, Mohammad Taheri, Soudeh Ghafouri-Fard
The role of liver microenvironment in hepatic metastasis
Tovah Williamson, Nikhila Sultanpuram, Hossein Sendi
Systemic treatment for lung carcinoids: from bench to bedside
Mariangela Torniai, Laura Scortichini, Francesca Tronconi, Corrado Rubini, Francesca Morgese, Silvia Rinaldi, Paola Mazzanti, Rossana Berardi
New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
Babita Agrawal
Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer
Evgeny Chirshev, Kerby C. Oberg, Yevgeniya J. Ioffe, Juli J. Unternaehrer
Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options
Trushil G. Shah, Dan Predescu, Sanda Predescu
Debutant iOS app and gene-disease complexities in clinical genomics and precision medicine
Zeeshan Ahmed, Saman Zeeshan, Ruoyun Xiong, Bruce T. Liang
From fiction to science: clinical potentials and regulatory considerations of gene editing
Maria Schacker, Diane Seimetz
Network vulnerability-based and knowledge-guided identification of microRNA biomarkers indicating platinum resistance in high-grade serous ovarian cancer
Xin Qi, Chunjiang Yu, Yi Wang, Yuxin Lin, Bairong Shen
Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients
Feng Zhao, Jili Wang, Meiqin Chen, Danni Chen, Sunyi Ye, Xinke Li, Xin Chen, Guoping Ren, Senxiang Yan
Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect
Dickson Kofi Wiredu Ocansey, Li Wang, Jingyan Wang, Yongmin Yan, Hui Qian, Xu Zhang, Wenrong Xu, Fei Mao
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment
Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen, Cecilie J. Sandberg, Swapnil Potdar, Iver A. Langmoen, Aki Laakso, Emília Gaál-Paavola, Markus Perola, Krister Wennerberg, Einar O. Vik-Mo